United States - English - NLM (National Library of Medicine)

oceanside pharmaceuticals - prednicarbate (unii: v901lv1k7d) (prednicarbate - unii:v901lv1k7d) - prednicarbate emollient cream 0.1% is a medium-potency corticosteroid indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid responsive dermatoses. prednicarbate emollient cream 0.1% may be used with caution in pediatric patients 1 year of age or older. the safety and efficacy of drug use for longer than 3 weeks in this population have not been established. since safety and efficacy of prednicarbate emollient cream 0.1% have not been established in pediatric patients below 1 year of age, its use in this age group is not recommended. prednicarbate emollient cream 0.1% is contraindicated in those patients with a history of hypersensitivity to any of the components in the preparations.

United States - English - NLM (National Library of Medicine)

e. fougera & co. a division of fougera pharmaceuticals inc. - prednicarbate (unii: v901lv1k7d) (prednicarbate - unii:v901lv1k7d) - prednicarbate 1 mg in 1 g - prednicarbate cream 0.1% (emollient) is a medium-potency corticosteroid indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid responsive dermatoses. prednicarbate cream 0.1% (emollient) may be used with caution in pediatric patients 1 year of age or older. the safety and efficacy of drug use for longer than 3 weeks in this population have not been established. since safety and efficacy of prednicarbate cream 0.1% (emollient) have not been established in pediatric patients below 1 year of age, its use in this age group is not recommended. prednicarbate cream 0.1% (emollient) is contraindicated in those patients with a history of hypersensitivity to any of the components in the preparations.

Canada - English - Health Canada

bausch health, canada inc. - prednicarbate - cream - 0.1% - prednicarbate 0.1% - anti-inflammatory agents

Australia - English - Department of Health (Therapeutic Goods Administration)

pharmacor pty ltd - zinc oxide, quantity: 75 mg/g; castor oil, quantity: 500 mg/g - cream - excipient ingredients: cetostearyl alcohol; white beeswax; arachis oil - soothe skin ; maintain/support skin health ; maintain/support skin integrity/structure

United States - English - NLM (National Library of Medicine)

amneal pharmaceuticals ny llc - difluprednate (unii: s8a06qg2qe) (difluprednate - unii:s8a06qg2qe) - difluprednate ophthalmic emulsion, 0.05%, a topical corticosteroid, is indicated for the treatment of inflammation and pain associated with ocular surgery. difluprednate ophthalmic emulsion, 0.05% is also indicated for the treatment of endogenous anterior uveitis. the use of difluprednate, as with other ophthalmic corticosteroids, is contraindicated in most active viral diseases of the cornea and conjunctiva including epithelial herpes simplex keratitis (dendritic keratitis), vaccinia, and varicella, and also in mycobacterial infection of the eye and fungal disease of ocular structures. teratogenic effects pregnancy category c difluprednate has been shown to be embryotoxic (decrease in embryonic body weight and a delay in embryonic ossification) and teratogenic (cleft palate and skeletal anomalies) when administered subcutaneously to rabbits during organogenesis at a dose of 1 to 10 mcg/kg/day. the no-observed-effect-level (noel) for these effects was 1 mcg/kg/day, and 10 mcg/kg/day was considered to be a teratogenic dose that was concurrently found in the toxic dose range for fetuses and pregnant females. treatment of rats with 10 mcg/kg/day subcutaneously during organogenesis did not result in any reproductive toxicity, nor was it maternally toxic. at 100 mcg/kg/day after subcutaneous administration in rats, there was a decrease in fetal weights and delay in ossification, and effects on weight gain in the pregnant females. it is difficult to extrapolate these doses of difluprednate to maximum daily human doses of difluprednate, since difluprednate is administered topically with minimal systemic absorption, and difluprednate blood levels were not measured in the reproductive animal studies. however, since use of difluprednate during human pregnancy has not been evaluated and cannot rule out the possibility of harm, difluprednate should be used during pregnancy only if the potential benefit justifies the potential risk to the embryo or fetus. it is not known whether topical ophthalmic administration of corticosteroids could result in sufficient systemic absorption to produce detectable quantities in breast milk. systemically administered corticosteroids appear in human milk and could suppress growth, interfere with endogenous corticosteroid production, or cause other untoward effects. caution should be exercised when difluprednate is administered to a nursing woman. difluprednate was evaluated in a 3-month, multicenter, double-masked trial in 79 pediatric patients (39 difluprednate; 40 prednisolone acetate) 0 to 3 years of age for the treatment of inflammation following cataract surgery. a similar safety profile was observed in pediatric patients comparing difluprednate to prednisolone acetate ophthalmic suspension, 1%. no overall differences in safety or effectiveness have been observed between elderly and younger patients.

United States - English - NLM (National Library of Medicine)

fougera pharmaceuticals inc. - prednicarbate (unii: v901lv1k7d) (prednicarbate - unii:v901lv1k7d) - prednicarbate 1.0 mg in 1 g - prednicarbate ointment 0.1% is a medium potency corticosteroid indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses. prednicarbate ointment 0.1% is contraindicated in those patients with a history of hypersensitivity to any of the components in the preparations.

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

ranvet pty. limited - nitrofurazone - topical cream, ointment, paste, gel, lotion - nitrofurazone nitrofuran active 2.0 mg/g - dermatological preps. - horse | colt | donkey | endurance horse | filly | foal | gelding | high performance horses | horses at stud | mare | pacer | pol - antibiotic - anti-infective | cracks, sores, wounds (assist healing) | open wounds - antibacterial | skin lesion | abrasions | abscesses | airsacculitis | antiseptic | avian mycoplasmas | bites | blackhead | body odours | bowed tendons | broad spectrum | burns | coccidiosis | coliform complex | conjunctivitis | cowpox | cracks | crusts | cuts | dandruff | dermatological disorders | dermatosis | dry skin | dysentery | eczema | endometritis | enteric diseases | enzootic pneumonia | feed efficiency | fungal infections | girth galls | infections | inflammed pads | itching | keratolytic | lacerations | mastitis | mycoplasmas | odours | open wounds | otitis | pruritis | queensland itch | respiratory disease | saddle rash | salmonellosis | scabs | scaly skin | sheath rot | skin irritations | sores | swine dysentery | teat cracking | teat infections | topical infections | udder sores | weight gain | wire cuts | wounds

Australia - English - Department of Health (Therapeutic Goods Administration)

moogoo skin care pty ltd - centella asiatica, quantity: 10 mg/g (equivalent: centella asiatica, qty 5 mg/g); sage oil dalmatian, quantity: 0.5 mg/g (equivalent: thujone, qty 0.15 mg/g); matricaria chamomilla, quantity: 10 mg/g (equivalent: matricaria chamomilla, qty 5 mg/g); aloe vera, quantity: 2 mg/g (equivalent: aloe vera, qty 20 mg/g) - cream - excipient ingredients: piroctone olamine; humulus lupulus; olive oil; cetostearyl alcohol; allantoin; polysorbate 60; citric acid; purified water; xanthan gum; squalane; almond oil; d-alpha-tocopheryl acetate - anti-inflammatory/relieve inflammation ; decrease/reduce/relieve symptoms of mild eczema/dermatitis ; decrease/reduce/relieve symptoms of mild psoriasis ; decrease/reduce/relieve skin dryness ; soothe skin ; decrease/reduce/relieve skin scaling/crusty skin ; helps reduce occurrence of skin dryness ; decrease/reduce/relieve symptoms of mild, superficial skin fungal infections ; soothe/relieve skin inflammation ; decrease/reduce/relieve skin irritation ; antipruritic/relieves itchy skin ; decrease/reduce/relieve skin redness ; relieve red skin rash ; helps enhance/promote skin health ; maintain/support skin health ; enhance/improve/promote skin healing ; maintain/support wound healing ; maintain/support skin repair/healing/regeneration

Australia - English - Department of Health (Therapeutic Goods Administration)

pro ma systems aust pty ltd - aloe vera, quantity: 15 mg/g (equivalent: aloe vera, qty 150 mg/g); hamamelis virginiana, quantity: 20 mg/g (equivalent: hamamelis virginiana, qty 20 mg/g); d-alpha-tocopherol, quantity: 10 mg/g - cream - excipient ingredients: glutamic acid; lecithin; purified water; potassium hydroxide; allantoin; retinol palmitate; phenoxyethanol; colecalciferol; glycerol; sunflower oil; stearic acid; cetostearyl alcohol; ceteareth-20; safflower oil; prunus armeniaca; glyceryl caprylate; benzyl alcohol; sorbitol; panthenol; self-emulsifying glyceryl monostearate - antioxidant/reduce free radicals formed in the body ; helps enhance/promote collagen formation ; maintain/support collagen formation ; decrease/reduce/relieve pimples ; decrease/reduce/relieve symptoms of mild psoriasis ; decrease/reduce/relieve skin dryness ; soothe skin ; decrease/reduce/relieve skin scaling/crusty skin ; helps reduce occurrence of skin dryness ; soothe/relieve skin inflammation ; decrease/reduce/relieve skin irritation ; antipruritic/relieves itchy skin ; decrease/reduce/relieve skin redness ; relieve red skin rash ; decrease/reduce skin sensitivity ; helps enhance/promote skin health ; maintain/support skin health ; helps enhance/improve/promote/increase skin hydration ; maintain/support skin hydration ; helps enhance/promote skin regeneration ; maintain/support skin regeneration ; helps decrease/reduce/relieve symptoms of minor skin wounds (cuts, scratches and abrasions) ; helps healing of mild skin burn/sunburns ; soothe/relieve mild skin burn/sunburns ; enhance/improve healing of minor skin wound/cuts/scratches/abrasions ; enhance/improve/promote skin healing ; maintain/support wound healing ; enhance/improve/promote skin repair/healing ; maintain/support skin repair/healing/regeneration

Australia - English - Department of Health (Therapeutic Goods Administration)

strides pharma science pty ltd - imiquimod, quantity: 12.5 mg - cream - excipient ingredients: benzyl alcohol; purified water; methyl hydroxybenzoate; isostearic acid; xanthan gum; glycerol; white soft paraffin; polysorbate 60; stearyl alcohol; propyl hydroxybenzoate; sorbitan monostearate; cetyl alcohol - ? treatment of solar (actinic) keratosis on the face and scalp (see precautions), and ,? primary treatment of confirmed superficial basal cell carcinoma where surgery is considered inappropriate, and ,? treatment of external genital and perianal warts/condyloma acuminata in adults (see precautions).